# Tadao Akizawa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tadao-akizawa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,487 |
| Field | Dialysis and Renal Disease Management |
| h-index | 67 |
| i10-index | 311 |
| Last Known Institution | SHOWA Medical University |
| OpenAlex ID | https://openalex.org/A5071555943 |
| ORCID iD | https://orcid.org/0000-0002-6150-9201 |
| Works | 607 |

## Researcher papers

- [Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)](https://scholariq.org/papers/mortality-risk-for-dialysis-patients-with-different-levels-of-serum-calcium/)
- [Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease](https://scholariq.org/papers/bardoxolone-methyl-in-type-2-diabetes-and-stage-4-chronic-kidney-disease/)
- [Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/iron-management-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder](https://scholariq.org/papers/clinical-practice-guideline-for-the-management-of-chronic-kidney-disease-mineral/)
- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study](https://scholariq.org/papers/health-related-quality-of-life-among-dialysis-patients-on-three-continents-the/)
- [2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease](https://scholariq.org/papers/2008-japanese-society-for-dialysis-therapy-guidelines-for-renal-anemia-in/)
- [HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients](https://scholariq.org/papers/hmg-coenzyme-a-reductase-inhibitor-use-is-associated-with-mortality-reduction-in/)
- [Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis](https://scholariq.org/papers/japanese-society-for-dialysis-therapy-guidelines-for-management-of/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Magnesium in Health and Disease](https://scholariq.org/topics/magnesium-in-health-and-disease/)

## Researcher university

- [SHOWA Medical University](https://scholariq.org/institutions/showa-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.